GAMMA Investing’s Orchestra BioMed OBIO Stock Holding History

GAMMA Investing’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.84K	Buy	+296	New	+$1.42K	﹤0.01%	3972
2025 Q2	–	Sell	-101	Closed	-$432	–	3862
2025 Q1	$432	Buy	+101	New	+$502	﹤0.01%	3695

Other funds holding OBIO

DSC

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

AFG

ABLE Financial Group Scottsdale, Arizona $640M AUM 16% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's OBIO Position: Q3 2026 in Review

GAMMA Investing opened a new position in Orchestra BioMed (OBIO) in Q3 2026: 296 shares worth $1.84K. The stake represents ﹤0.01% of the portfolio and ranks #3972 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in OBIO as recently as Q1 2025.

GAMMA Investing first reported a position in OBIO in Q1 2025 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.

GAMMA Investing held 296 shares of Orchestra BioMed worth $1.84K as of Q3 2026.
Orchestra BioMed was a new GAMMA Investing position in Q3 2026.
Orchestra BioMed made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3972 holding.
GAMMA Investing first reported a position in Orchestra BioMed in Q1 2025 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.